Second Order/ stocks
← All runs·Jun 7, 2026
CRWV
CRWV
HOLD

CoreWeave is growing fast but losing money, drowning in debt, and just filed paperwork to sell more stock — while insiders keep selling. At $100 it's sitting right on a key support line, so it could bounce toward the $140 analyst target, but it could just as easily get cut in half if H2 execution slips. Best to wait for either a clean bounce off support with volume or a capital raise to clear the overhang before committing.

P(upside)42%
coin-flip = 50%
Conviction0.49
Horizon4-8 weeks
ResolutionPending graded vs the realized move

Price

Price at analysis
$100.39

The setup

starter only if initiating — prefer no position; 91% annualized vol and equity shelf overhang make sizing dangerous

The case

● Bull — what supports it

Revenue is growing 111.6% YoY into a reported $99.4B backlog with Anthropic/Meta wins, and consensus analyst target of $140.18 implies ~40% upside from $100.39. The stock is sitting on its 200-DMA ($99.93) after a -27.24% one-month washout, a level where contrarian bounces and short squeezes are plausible given 91% annualized vol.

● Bear — what refutes it

Forward PE of -143x, profit margin of -25.6%, and debt-to-equity of 738x describe a company funding GPU capex with leverage it cannot service from operations. The June 5 mixed shelf filing plus uninterrupted insider selling telegraphs near-term dilution, and Q2 guidance loads ~90% of FY adjusted operating income into H2 — an execution bar the critic correctly flags as inconsistent with -$4.71B Q1 FCF and $31–35B annual capex. Price is below the 50-DMA ($106.74) with -27.24% 1M momentum, and bear analyst targets reach $36–67.

What would change our mind

Drake commits in advance to what would prove this call wrong — falsifiers, not hindsight.

  • Clean break and close below 200-DMA ($99.93) on volume, or any equity raise priced below $90, flips this to SELL
  • Anchor-tenant contract expansion (Microsoft/Meta/Anthropic) or H2 operating income tracking confirmed above guide midpoint flips to BUY
  • Insider buying or withdrawal/non-use of the June 5 shelf within 60 days materially reduces dilution overhang

The panel — 3 specialists

Fundamentalbearish
conviction 0.65
  • Deeply unprofitable: trailing net margin of -25.6% with no path to profitability visible in forward estimates (fwd PE of -143x)
  • Extreme leverage: debt-to-equity of 738x signals massive GPU financing obligations relative to thin equity base
  • Revenue growth of 111% YoY is impressive but priced in and may reflect backloaded contract recognition risk
  • Price sits below 50-DMA (~$106) but barely above 200-DMA (~$99), suggesting fragile technical support
  • Annualized volatility of 91% makes this a highly speculative instrument; -27% in 1 month signals near-term momentum breakdown
Risks: Analyst consensus target of $140 (~40% upside) could catalyze a sharp reversal if sentiment shifts positive; Hyperscaler AI capex surge could extend CoreWeave's revenue runway beyond current expectations; Short squeeze risk given volatile nature and high short interest plausible in a stock down 28% over 1 year
Technicalbearish
conviction 0.62
  • Price ($100.39) is below 50-day MA ($106.74), indicating near-term downtrend
  • 1-month return of -27.24% signals sharp recent selling pressure
  • Annualized volatility of 91% reflects extreme risk regime
  • Debt-to-equity of 738x is exceptionally high, raising solvency/dilution risk
  • Analyst consensus target of $140.18 implies ~40% upside, but negative forward PE (-143x) signals unprofitability
Risks: 3-month return of +37.54% shows price can rebound violently — short squeeze risk is real; Price is near 200-day MA ($99.93), which may act as support and attract buyers; AI infrastructure demand growth (111.6% revenue growth) could re-rate stock quickly
Newsneutral
conviction 0.45
  • Q1 2026 (May 7, ~31 days ago): Revenue beat ($2.08B vs $1.97B expected, +112% YoY) but EPS miss (-$1.12 adj vs -$0.90 expected); stock fell ~10-13% post-earnings (CNBC, timothysykes.com)
  • Q2 2026 guidance soft ($2.45B-$2.60B midpoint vs $2.69B consensus) and FY CapEx raised to $31B-$35B — puts heavy weighting on H2 execution (TheStreet/Wells Fargo, May 8)
  • RECENT (June 5, 2 days ago): Another insider sale flagged; Director Jack D. Cogen sold 742,307 shares for ~$78.7M on May 29; insiders have ONLY sold in past 3 months with zero open-market buys (TipRanks, SimplyWallSt)
  • RECENT (June 5, 2 days ago): CoreWeave filed an automatic mixed securities shelf — signals future equity/debt issuance potential dilution; stock near 200-day MA ($99.93) and below 50-day MA ($106.74), -27% in 1 month (CNBC/snapshot)
  • Bull offset: $99.4B revenue backlog (+4x YoY), Anthropic/Meta customer wins, Jane Street private placement at $109 (Apr 15), analyst consensus Buy ~$130-$140 target (~30-40% upside), but 6% of analysts rate Sell with $67 target (TipRanks, public.com)
Risks: Equity shelf filing (June 5) + sustained insider selling creates near-term supply overhang and dilution risk at current prices; Heavy debt load (~$27B long-term debt, D/E 738x per snapshot) + Q1 FCF -$4.71B; rising component costs may squeeze multi-year fixed-price contracts; Securities class-action lawsuits alleging misleading statements on scaling/data center timelines add legal/reputational tail risk (Kavout, CNN, Feb 2026)
Analyzed Jun 7, 2026 Resolves Jul 22, 2026 Schema v2 Run f28b43ae5a8ebe66 Engine Drake · 3-specialist panel

Forward-only: this call is graded against the future, on its resolution date — never backfilled.